- GloPID-R action
- GloPID-R coordination
- WHO action
WHO Office in China is informed that cases of pneumonia of an unknown cause had been detected in Wuhan City, Hubei Province, China. The Chinese authorities identified this to be a previously unknown type of coronavirus (COVID-19). Following the outbreak, the number of confirmed cases of COVID-19 increased rapidly across the globe.
WHO Office in China is informed that cases of pneumonia of an unknown cause had been detected in Wuhan City, Hubei Province, China…
Read moreGloPID-R Members and other major players involved in infectious disease outbreaks worldwide reacted rapidly to this emerging epidemic, working closely with WHO to identify the specific funding research priorities needed to tackle the disease. GloPID-R Chairs and Scientific Advisor immediately launched consultations to coordinate future action in line with the GloPID-R global response strategy.
GloPID-R Members and other major players involved in infectious disease outbreaks worldwide reacted rapidly to this emerging epidemic…
Read moreFollowing the spread of COVID-19 from the People’s Republic of China to 20 other countries in the first 6 weeks of 2020, and on the recommendations of the Emergency Committee, the WHO Director General declared the outbreak a Public Health Emergency of International Concern (PHEIC).
StatementWHO declared the outbreak a Public Health Emergency of International Concern
Read moreThe Joint Statement on Data-sharing in Public Health Emergencies developed by Wellcome Trust and endorsed by GloPID-R was published on January 31. Timely and transparent sharing of data in a public health emergency (PHE) is vital. In light of the threat presented by the COVID-19 outbreak, signatories to the 2016 Joint Statement on data sharing in public health emergencies were invited to reaffirm their commitment to ensure research findings of relevance are shared rapidly with WHO by signing the ‘Joint Statement on sharing research data and findings relevant to the novel coronavirus (nCoV) outbreak’. The number of signatories increased from 67 in 2016 to 117 today.
Joint statementThe Joint Statement on Data-sharing in Public Health Emergencies developed by Wellcome Trust and endorsed by GloPID-R was published….
Read moreRapid research fundings were launched worldwide by GloPID-R members in order to fund COVID-19 scientific priorities. Members of the GloPID-R network immediately coordinated to identify the existing, funded research projects in this area and began launching emergency calls for funding.
Covid-19 funding opportunitiesRapid research fundings were launched worldwide by GloPID-R members in order to fund COVID-19 scientific priorities…
Read moreThe GloPID-R–WHO Global Research and Innovation Forum took place at WHO Headquarters, Geneva, Switzerland on February 11-12. To accelerate the generation of critical scientific information and develop the medical products needed to control COVID-19, key knowledge gaps and research priorities must be identified. To this end, WHO and GloPID-R invited participants from the global scientific community, public health and regulatory bodies, member states, research funders and bioethical organizations to attend this forum.
Meeting summary Meeting programme Overview of state-of-the-art and key knowledge gap outline News releaseThe GloPID-R–WHO Global Research and Innovation Forum took place at WHO Headquarters, Geneva, Switzerland…
Read moreGloPID-R attended the Global Coordination Mechanism meeting of the WHO R&D Blueprint
GloPID-R attended the Global Coordination Mechanism meeting of the WHO R&D Blueprint
Read moreOn the basis of the work carried out during the Global Research and Innovation Forum, the coordinated Global Research Roadmap was published on March 6, 2020. The document presents the immediate, mid-term and longer- term priorities to build a robust global research response to COVID-19.
Global Research Road MapPublication of the coordinated Global Research Roadmap
Read morePointing to the over 118,000 cases of the coronavirus illness in over 110 countries and territories around the world and the sustained risk of further global spread, the WHO Director General declared on March 12, 2020 that COVID-19 could be characterized as a pandemic.
WHO declared the COVID-19 outbreak a pandemic
Read moreGloPID-R Response Strategy Coordination meetings were held to pinpoint research gaps to identify and set research priorities, and select rapid research projects
GloPID-R Response Strategy Coordination meetings were held to pinpoint research gaps to identify and set research priorities, and select rapid research projects
Read moreContinuing GloPID-R coordination of rapid funding for research priorities and the selection of relevant projects
GloPID-R continues coordination of rapid funding for research priorities and the selection of relevant projects
Read moreThe GloPID-R – UKCDR live Research Project Tracker was launched on April 3 to support a more effective and coherent global research response. This live database of funded research projects on COVID-19 provides an overview of funded research projects mapped against the priorities identified in the WHO Coordinated Global Research Roadmap. It will be regularly updated as new funding decisions are announced. The aim of the joint GloPID-R – UKCDR initiative is to help funders and researchers identify gaps and opportunities and inform future research investments or coordination needs.
Covid-19 Research Project TrackerThe GloPID-R – UKCDR live Research Project Tracker was launched…
Read moreGloPID-R attended the virtual Global Research and Innovation Forum of the WHO R&D Blueprint
GloPID-R attended the virtual Global Research and Innovation Forum of the WHO R&D Blueprint
Read moreGloPID-R convened global funders, researchers & stakeholders to virtual COVID-19 Research Synergies Meetings on the themes of Vaccines, Therapeutics, Understanding Transmission & Social Sciences. A panel discussion completed the series of meetings. Participants included GloPID-R members and the researchers funded by their COVID-19 rapid response calls, representatives from the WHO, and other major research and funding organisations alongside contributors from countries affected by second peaks, waves or high incidence.
These meetings provided a platform to promote and establish collaboration and synergies between researchers funded by GloPID-R members. This maximized the use of available resources, generating connections between ongoing research projects, creating opportunities to share information on progress, barriers and outstanding research gaps and facilitating the progress of a collective effort to end COVID-19.
Concept note Meeting summaries Programs & videosGloPID-R convened global funders, researchers & stakeholders to virtual COVID-19 Research Synergies Meetings…
Read moreCOVID CIRCLE – COVID-19 Research Coordination and Learning is a partnership between UKCDR and GloPID-R and has been developed to harness activities such as the continual mapping and analysis of global COVID-19 funding through the COVID-19 Research Project Tracker. This will enable COVID CIRCLE to coordinate funding efforts, connect networks of researchers, and collate learnings to inform future epidemic and pandemic responses with a focus on lower-resource settings.
Learn more about the COVID CIRCLELaunch of the UKCDR-GloPID-R initiative COVID CIRCLE - COVID-19 Research Coordination and Learning
Read moreThere is an urgent need for robust scientific studies into the long-term impact of COVID-19 in both adults and children, and for healthcare providers to be informed to support prevention, assessment, rehabilitation and interventions to improve recovery and patient outcomes.
During the 2-day, Long COVID Forum, the objectives were to gain a better understanding of Long COVID and to define research gaps for funders and researchers to take forward. Topics included:
ISARIC and GloPID-R organized the Long COVID Virtual Forum in collaboration with the Long COVID Support…
Read moreGloPID-R members gathered virtually on December 23, 2020 to discuss the new variant of SARS-CoV-2. GloPID-R Scientific Advisor, Marion Koopmans, presented an understanding of viral mutations and the biological implications; updates were provided by GloPID-R Vice chairs: Jeremy Farrar for the UK and Charles Wiysonge for South Africa. Further information for the UK was given by the University of Oxford and the WHO presented their situation update and expert guidance.
GloPID-R convened members to a web conference to discuss the new variant of SARS-CoV-2.
Read moreThe GloPID-R-UKCDR COVID CIRCLE Researcher Coordination Platform was launched on February 3 to facilitate information sharing on COVID-19 research and bring together the global research community working on COVID-19 research in and for low resource settings. The platform’s key features are the COVID-19 Resource hub; a map of global and regional networks relevant to epidemics research and a listing of COVID-19 events around the world.
COVID CIRCLE Researcher Coordination PlatformThe GloPID-R-UKCDR COVID CIRCLE Researcher Coordination Platform was launched on February 3 to facilitate information sharing on COVID-19 research
Read moreGloPID-R - UKCDR’s COVID CIRCLE with the COVID-19 Clinical Research Coalition convened this virtual event bringing together global research funders with the community of researchers who are actively undertaking research into COVID-19 across LMICs.
The four main sessions covered were:
The GloPID-R - UKCDR COVID CIRCLE with the COVID-19 Clinical Research Coalition held an online event on COVID-19 Research in LMICs…
Read moreYou can choose which cookies you want to allow across the site by adjusting the toggles below. Update your cookie preferences at any time by clicking the "Cookies Settings" link on any webpage, which will return you to this preference centre. For more information, click "Cookies Details" below, and read our Cookies Policy.
You can choose which cookies you want to allow across the site by adjusting the toggles below. Update your cookie preferences at any time by clicking the "Cookies Settings" link on any webpage, which will return you to this preference centre. For more information, click "Cookies Details" below, and read our Cookies Policy.
Certain cookies are necessary to ensure the proper functioning of the site. If you wish, you can configure your Internet browser to restrict or block these cookies.
Social networks and video sharing services improve the usability of the site, enrich its content, increase its visibility and help promote it via content sharing.
These cookies allow us to establish statistics relating to the frequentation and use of the site, by determining for example the number of visits to the site and what are the most or least visited pages, by evaluating the navigation of users on the site and by identifying possible dysfunctions. They thus contribute to the constant improvement of the site.